FEATURED COMPANIES
- Abbott Laboratories
- Cook Medical
- GE Healthcare
- Invitae Corporation
- Kitazato Corporation
- Natera, Inc.
The global in-vitro fertilization market is projected to reach $51.51 billion by 2030. The study highlights that the market is set to witness a CAGR of 9.37% during the period 2020-2030.
Infertility is a serious health issue worldwide, affecting approximately 8%-10% of couples worldwide. According to CDC, 2013 and Office on Women’s Health, 2019 reports, about 9% of men and 10% of women aged 15 to 44 reported infertility problems in the U.S., and according to the Reproductive Biological Endocrinology, 2015 report, around 48.5 million couples experience infertility, globally. In response to these issues, countries across the globe are striving hard to increase their fertility rates, thereby promoting high adoption of assisted reproductive technologies (ART). ART are cutting-edge technologies that help to treat infertility by manipulating sperm and/or eggs outside the human body.
The global in-vitro fertilization market consists of systems, media, and reagents, and pharmaceuticals used to carry out the entire procedure, from monitoring and stimulating a woman's ovulatory process to the final implantation of the embryo into the concerned woman’s fallopian tube to bringing out a successful pregnancy. The increasing incidence of infertility owing to lifestyle changes, such as an increase in the median age of first-time motherhood, is a major factor contributing to the growth of the global in-vitro fertilization market.
Healthcare experts have found in-vitro fertilization to be one of the most rapidly evolving techniques, and the global market for in-vitro fertilization is predicted to grow at a CAGR of 9.37% over the forecast period 2020-2030. An increase in the trend of delayed pregnancies, changing lifestyles in urban areas, and increased age of parenthood bolster the growth of the global IVF market. The following report presents the reader with an opportunity to unlock comprehensive insights with respect to the global IVF market and helps in forming well-informed strategic decisions. The market research study also offers a wide perspective of the different types of products and services available in the market and their impact on the healthcare sector by providing critical insights into the direction of its future expansion.
The global IVF market is largely dominated by companies such as The Cooper Companies Inc., Vitrolife AB, Cook Medical, Merck KGaA, Fujifilm Holdings Corporation, and other enterprises. Declining fertility rates, changing lifestyles in urban areas, and increased age of parenthood are expected to be the primary factors driving the growth of the global IVF market. Government funding encouraging infertility treatments in addition to the industrial revolutions and technological advancements in the ART field is further expected to accelerate the growth of the market during the forecast period 2020-2030.
Based on region, Europe is the dominating region for the global in-vitro fertilization market in the year 2019. Low fertility rates and flexible government regulations are the two most prominent factors contributing to the growth of the IVF market in Europe. In the Asia-Pacific region, China, Japan, India, Australia, and New Zealand are among the top five countries generating the highest revenues compared to other countries of the region.
Within the research report, the market is segmented based on product, services, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.
Competitive Landscape
The global IVF market is distributed among suppliers and service providers. Cooper Surgical, Vitrolife AB, Merck KGaA, and Cook Medical are some of the key suppliers to this market. Among the service providers, companies like Progyny, Natera, and Invitae Corp. are the major service providers offering IVF diagnostic and testing services.
The global in-vitro fertilization market is currently dominated by Cooper Companies, Inc., followed by Vitrolife AB. The market dominance of Cooper Companies, Inc. can be attributed to a large product offering in media, reagents, and consumables segments. Merck KGaA holds the third largest share, owing to its diverse range of product offerings in consumables (including media, kits, and accessories) and systems.
This comprehensive study of the global in-vitro fertilization market covers the following:
- Market numbers on micro-segments that are influencing the market
- More than 1000 products present in the market
- Pricing data for products and procedures
- Over 250 brands were evaluated
- Market share analysis for more than 20 product categories
- End-user preference data for over 50 end users
- Detailed global and regional market share analysis, including the scrutiny of more than 16 countries
- Data study of more than 25 companies
Besides these parameters, the study also encompasses the market growth drivers, opportunities, market restraining factors, competition mapping, segmental analysis, and a visual dashboard of 1000+ products.
The study indicates that the declining fertility rates, changing lifestyles in urban areas, and increased age of parenthood are expected to be the primary factors driving the growth of the global IVF market. Government funding encouraging infertility treatments in addition to the industrial revolutions and technological advancements in the ART field is further expected to accelerate the growth of the market during the forecast period 2020-2030.
The study highlights the various emerging opportunities, such as growth in emerging nations, technological advancements of time-lapse technology, and advances in embryo biopsy and genetic screening.
The market intelligence additionally throws a spotlight on the key industry trends that have a humungous influence in shaping the industry going forward. Some of these trends include the emergence of advanced IVF testing solutions, replacement of existing IVF equipment, exploration of new procedures, and several other key trends.
To gain a holistic view of the market, data from different segments of the market has been analyzed minutely. These segments include products, services, types of products offered, IVF types, procedures used, end users, and regions. Each of these segments is further categorized into sub-segments and micro-segments to compile an in-depth study.
The end-user and pricing analysis of the global market includes data analysis on the satisfaction level of different procedures, pricing analysis of equipment and consumables used while carrying out the testing and procedures. The study is majorly centered on the sub-segments and micro-segments of the different product markets, such as systems, media and reagents, and accessories and consumables. The systems are further categorized into gamete collection and sorting systems, sample handling systems, storage and maintenance systems, and other IVF systems (support equipment, witness systems, and others). The procedure segment under the services category is further categorized into a fresh donor, fresh non-donor, frozen donor, and frozen non-donor.
To emphasize the dominance of the fresh non-donor procedure over the procedure segment under the services category of in-vitro fertilization market in 2020 and 2030, a Senior Research Analyst states, "The reason for market growth and the dominance of fresh non-donor procedure over other procedures can be attributed to the technological advancements in cryopreservation techniques of embryos. In addition, the high success rate of this procedure in the first attempt is the main factor why this segment holds major market shares. For instance, conception is more likely after fresh than frozen embryo transfer with recipients but is like donor conception rates."
Key insights are drawn from in-depth interviews with the key opinion leaders of more than 25 leading companies, market participants, vendors, and service providers.
The study also offers strategic recommendations that can help organizations in tracking various products, trends, and technologies that are changing the dynamics of the market. The recommendations also offer bespoke research services to help organizations meet their objectives.
Key Questions Answered in This Report
- What is in-vitro fertilization?
- What are different types of systems, media, and reagents available in the market, and what are they used for? What are the key companies offering these devices and reagents? What would be the global market value for each of these systems, media, and reagents for the time between 2020 and 2030?
- Based on systems, which IVF system type is anticipated to witness a massive rise in the demand in the forecast period? Based on reagents, which reagent type is anticipated to witness a massive rise in the demand in the forecast period?
- What are the different testing services involved in IVF procedures, and what are the key companies offering them? What would be the global market value for services for the period 2019-2030?
- What are the major drivers, challenges, and opportunities of the global IVF market?
- What are the key developmental strategies implemented by the key players to stand out in this market?
- What are the leading companies dominating the global IVF market? What is the share of these companies in the global IVF market?
- What are the regulations pertaining to the global IVF market? What initiatives are implemented by different government bodies regulating the development and commercialization of IVF devices?
- By end-user type, what would the market value of the leading segments of the global IVF market be? By procedure type, what would the market value of the leading segments of the global IVF market be?
- How will each segment of the global IVF market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2030?
- How will the industry evolve during the forecast period 2020-2030?
- What is the market scenario for the IVF services market in different regions?
- What are the key trends of different regions in the IVF market? Which country would contribute to the highest sales of the IVF market during the forecast period 2020-2030?
Who should buy this report?
- Manufacturers of systems, media and reagents, accessories, and consumables
- Companies in the services market of in-vitro fertilization
How can market intelligence on in-vitro fertilization add value to an organization’s decision-making process?
- Aid in product development
- Help in targeting a segment for launching a new product
- Offer go-to market strategies for the different product type
- Support in diversifying the product portfolio basis risk and progression of technology
- Help in analyzing technological substitutes and compare the types
- Offer tailor-made solutions based on the throughput of different labs
- Aid in understanding the end-user requirement
- Assist in exploring the newer procedures
- Support in analyzing the competitors’ funding scenario
What is the estimated value of the Global In-Vitro Fertilization Market?
What is the growth rate of the Global In-Vitro Fertilization Market?
What is the forecasted size of the Global In-Vitro Fertilization Market?
Who are the key companies in the Global In-Vitro Fertilization Market?
FEATURED COMPANIES
- Abbott Laboratories
- Cook Medical
- GE Healthcare
- Invitae Corporation
- Kitazato Corporation
- Natera, Inc.
i) Executive Summary
LOADING...
- Abbott Laboratories
- Agilent Technologies, Inc.
- Boston IVF
- Care Fertility
- Cook Medical
- Esco Group of Companies
- F. Hoffmann-La Roche Ltd.
- FUJIFILM Irvine Scientific
- GE Healthcare
- Genea Limited
- Illumina, Inc.
- Invitae Corporation
- IVFtech ApS
- Kaiser Permanente
- Kitazato Corporation
- Laboratory Corporation of America Holdings (Labcorp)
- Merck KGaA
- Monash IVF Group
- Natera, Inc.
- Progyny, Inc.
- The Cooper Companies Inc.
- Thermo Fisher Scientific, Inc.
- Vitrolife AB